GEX
LIVE

Serial Number

79068397

Owner

Glycotope GmbH

Attorney

LEIGH ANN LINDQUIST

Filing Date

Nov 27, 2008

Add to watchlist:

No watchlists yet
View on USPTO

GEX Trademark

Serial Number: 79068397 • Registration: 3870245

GEX is a trademark filed by Glycotope GmbH on November 27, 2008. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Glycotope GmbH (13 trademarks)

Robert-Rössle-Str. 10

Entity Type: 99

Trademark Details

Filing Date

November 27, 2008

Registration Date

November 2, 2010

Published for Opposition

August 17, 2010

Goods & Services

[ Pharmaceutical and veterinary preparations for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; sanitary preparations for medical purposes; dietetic foods adapted for medical use; food for babies; medical plasters; materials for medical dressings; materials for dental filling and impression materials for dental purposes; disinfectants for sanitary purposes; preparations for destroying vermin; fungicides, herbicides; adjuvants for medical purposes; Medicines for human and veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, [ allergies, cardiovascular diseases, ] infectious diseases, [ neurological diseases, ] gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological preparations for medical purposes; dietetic food adapted for medical purposes; enzyme, proteins, antibodies, cells, microorganisms as well as fragments, fractions, elements and lysates thereof for medical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine, and as nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; vaccines; carbohydrates for medical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; cultures of microorganisms for medical or veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; cultures of human cells for medical or veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; medical drinks for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; microorganisms, cells and preparations containing elements, fragments, fractions and lysates of microorganisms or cells for medical and veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological therapeutics, namely, therapeutics containing cells, microorganisms, proteins, glycoproteins, peptides, glycopeptides or modified or conjugated versions thereof ; milk ferments for pharmaceutical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; nutritional additives and nutritional supplement additives for medical purposes for use in foods and dietary supplements for human consumption; nutrients for medical purposes, namely, enzymes, proteins, antibodies, cells, microorganisms as well as fragments, fractions, elements and lysates thereof as nutritional additives; sugar and carbohydrates for medical purposes, namely, therapeutically and prophylactically active sugar and carbohydrates, dietetic sugar and carbohydrates, sugar and carbohydrate replacements ]

[ Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fertilising preparations; fire extinguishing compositions; tempering and soldering chemicals; chemical substances for fermenting and preserving food stuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; bacteria and cell preparations and elements, fragments, fractions and lysates thereof, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment, bacteria and cell preparations for use in expression of engineered or glycosylated proteins and peptides; preparations containing bacteria and cells, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment; biological preparations for laboratories, except for medical or veterinary purposes, namely, for use in bacterial and cell engineering, cultivation, harvesting, protein production; chemical preparations for analysis in laboratories, namely, preparations for protein, peptide, engineered proteins and peptides, glycoproteins, glycosylation, antibody or antigen analysis, preparations comprising antibody reagents used for the detection of antigens; chemical preparations for scientific purposes; chemical reagents except for medical or veterinary purposes and biological reagents in the nature of reagents for use in protein production, bacterial and cell engineering, cultivation and harvesting, probes for detecting and analyzing molecules in protein or nucleotide arrays, except for medical or veterinary purposes; diagnostic preparations, except for medical or veterinary purposes; enzymes, proteins and respective preparations for industrial purposes, namely, engineered proteins, glycosylated proteins, antibodies, enzymes for use in glycosylation, enzyme substrates, proteins used in the manufacture of cosmetics, beverages, food products and food supplements; ferments for chemical purposes, namely, yeast, bacterium, mold, or enzyme, that causes fermentation; in-vitro diagnostics, other than for medical purposes; carbohydrates for use in the manufacture of food and nutraceuticals; cultures of microorganisms and cells and elements, fragments, fractions and lysates thereof, other than for medical or veterinary purposes, namely, cultures of microorganisms and cells other than for medical and veterinary use, microorganism or cell cultures for use in protein production, food manufacturing, scientific research, waste water treatment, cultures of microorganisms or cells for use in expression of glycosylated proteins and peptides; expression systems for proteins and peptides comprising cells, particularly human cells and microorganisms suitable for expressing engineered or glycosylated proteins or peptides, or capable of providing optimized glycosylation; milk ferments for medical research purposes ]

Scientific and technological services and research and designer services relating thereto, namely, scientific research, scientific analysis, technology consultation and research, product development and optimization in the field of biotechnology, protein production, glycosylation, optimization of protein, antibody and enzyme activity, [ bacteria ] and cell engineering, cultivation and harvesting; industrial analysis and research services in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, [ bacteria ] and cell engineering, cultivation and harvesting; [ design and development of computer hardware and software; ] biological research; services of a [ chemical or ] biological laboratory; [ technical surveys, namely, ] conducting biotechnology surveys, [ pharmacology surveys; ] conducting scientific surveys in the field of biotechnology, [ bacterial and ] cell engineering, protein production, glycosylation; research and development in the field of [ bacteriology, ] cytology, antibody technology, [ chemistry, ] immunology, [ cosmetics of expression systems in the nature of glycosylation of proteins, peptides, antibodies and enzymes, particularly for proteins and peptides; quality control; ] research and development of new products and technologies in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, [ bacteria and ] cell engineering, cultivation and harvesting for others; technology and scientific consultancy in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, [ bacteria and ] cell engineering, cultivation and harvesting; research and development in the field of glycomics, expression systems in the nature of glycosylation of proteins, peptides, antibodies and enzymes, development and improvement of cells, cell lines [ and microorganisms, ] antibody-engineering, optimised biological therapeutics, [ nutraceuticals, and food and nutritional supplements; ] research, quality control, technology consultancy and product development in the field of proteins, antibodies, [ microorganisms ] and cells; research and development in the field of [ microorganisms and ] cells

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 25, 2025 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
Oct 2, 2022 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 23, 2022 INPS
INVALIDATION PROCESSED
Aug 23, 2022 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 30, 2022 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Oct 30, 2021 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Oct 30, 2021 71.P
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Oct 28, 2021 EROP
POST REGISTRATION ACTION MAILED - SEC.71
May 6, 2021 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 20, 2021 APRE
TEAS SECTION 71 RECEIVED
Nov 2, 2020 ES71
AMENDMENT UNDER SECTION 7 - PROCESSED
Jul 8, 2020 A7OK
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 16, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 16, 2019 REAP
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Nov 2, 2019 REM4
INTERNATIONAL REGISTRATION RENEWED
Dec 13, 2018 RNWL
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 4, 2018 APRE
TEAS SECTION 7 REQUEST RECEIVED
Jun 1, 2018 ES7R
AMENDMENT UNDER SECTION 7 - PROCESSED
Mar 30, 2018 A7OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 30, 2017 APRE
TEAS SECTION 7 REQUEST RECEIVED
Oct 20, 2017 ES7R
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jun 23, 2017 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jun 23, 2017 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 20, 2017 APRE
TEAS SECTION 71 & 15 RECEIVED
Apr 27, 2017 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Dec 14, 2013 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 18, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 11, 2011 FICS
FINAL DISPOSITION PROCESSED
Feb 11, 2011 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 2, 2011 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 2, 2010 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 17, 2010 NPUB
PUBLISHED FOR OPPOSITION
Aug 17, 2010 PUBO
EXAMINERS AMENDMENT MAILED
Jul 16, 2010 CNEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 15, 2010 TCCA
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 15, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2010 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 15, 2010 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jul 15, 2010 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 15, 2010 ZZZX
EXAMINERS AMENDMENT MAILED
Jul 15, 2010 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2010 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 15, 2010 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jul 15, 2010 CNEA
FINAL REFUSAL MAILED
Jan 20, 2010 CNFR
FINAL REFUSAL WRITTEN
Jan 19, 2010 CNFR
CORRECTION TRANSACTION RECEIVED FROM IB
Jan 1, 2010 CRCV
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Dec 31, 2009 CORN
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2009 CRFA
ASSIGNED TO LIE
Dec 28, 2009 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 14, 2009 TROA
REFUSAL PROCESSED BY IB
Jul 10, 2009 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 15, 2009 RFCS
REFUSAL PROCESSED BY MPU
Jun 15, 2009 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 13, 2009 RFCR
NON-FINAL ACTION WRITTEN
Jun 12, 2009 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 9, 2009 MAFR
ASSIGNED TO EXAMINER
Jun 5, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 5, 2009 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 4, 2009 REPR